SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies

Putilina M.V.; Grishin D.V.

doi:https://doi.org/10.17116/jnevro202012008258

Close metadata

Recommended articles:

Cytokine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12

The main mechanisms of development of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18

A comprehensive study of Alzheimer’s disease biomarkers in plasma and cerebrospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53

Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60

Cognitive impairment in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73

Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80

Comparative study of cognitive impairment in subgroups of bipolar affective disorder types I and II, occurring with and without psychotic symptoms. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):7-11

Relationship between stroke-associated pneumonia and long-term outcomes of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):57-61

Study of the levocarnitine efficacy for the treatment of moderate cognitive impairment in patients with hypertension. Russian Journal of Preventive Medicine. 2025;(4):45-50

Potential of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87

Abstract:

The pandemic caused by the SARS-CoV-2 virus (COVID-19) made it necessary to evaluate in more detail the processes of neuroinflammation as an integral component of the pathogenesis of viral infection. The acute neuroinflammatory response includes the activation of resident tissue macrophages in the CNS and the subsequent release of various cytokines and chemokines, which probably activates oxidative stress, causing long-term neuronal damage. This makes urgent the search for drugs with indirect anti-inflammatory effects with proven effectiveness. From this point of view, it is worth further studying the treatment of patients with COVID-19 with dipyridamole, which, with its antiviral activity and anti-inflammatory effect, inhibiting acute inflammation and progressive fibrosis, is the drug of choice, especially for patients with early signs of elevated D-dimer concentrations and pronounced clinical symptoms of microangiopathy.

Keywords:

SARS-CoV-2 coronavirus

neuroinflammation

cytokine storm

neurodegeneration

cognitive impairment

potential therapy strategies

dipyridamole

Authors:

Putilina M.V.

Pirogov Russian National Research Medical University

ORCID: 0000-0002-8655-8501

Grishin D.V.

Pirogov Russian National Research Medical University;
Filatov City Clinical Hospital No. 15

Received:

11.09.2020

Accepted:

14.09.2020

Close metadata

References:

Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, Hao SR, Jia HY, Cai H, Zhang XL, Yu GD, Xu KJ, Wang XY, Gu JQ, Zhang SY, Ye CY, Jin CL, Lu YF, Yu X, Yu XP, Huang JR, Xu KL, Ni Q, Yu CB, Zhu B, Li YT, Liu J, Zhao H, Zhang X, Yu L, Guo YZ, Su JW, Tao JJ, Lang GJ, Wu XX, Wu WR, Qv TT, Xiang DR, Yi P, Shi D, Chen Y, Ren Y, Qiu YQ, Li LJ, Sheng J, Yang Y. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020 Mar 24;pii: gutjnl-2020-320926. https://doi.org/10.1136/gutjnl-2020-320926
Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J, Wang D, Liu C, Meng Y, Cui L, Yu J, Cao H, Li L. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). J Intern Med. 2020 Mar 27. https://doi.org/10.1111/joim.13063
Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010 Feb;129(2):154-169. https://doi.org/10.1111/j.1365-2567.2009.03225.x
Streit WJ, Xue QS, Braak H, del Tredici K. Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain. Glia. 2014;62(1):96-105. https://doi.org/10.1002/glia.22589
Walker AK, Kavelaars A, Heijnen CJ, Dantzer R. Neuroinflammation and comorbidity of pain and depression. Pharmacological reviews. 2013;66(1):80-101. https://doi.org/10.1124/pr.113.008144
Singhal G, Jaehne EJ, Corrigan F, Toben C, Baune BT. Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci. 2014;8:315. https://doi.org/10.3389/fnins.2014.00315
Putilina MV. Endothelium as a target for new therapeutic strategies in cerebral vascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(10):122-130. (In Russ.). https://doi.org/10.17116/jnevro2017117101122-130].
Gülke E, Gelderblom M, Magnus T. Danger signals in stroke and their role on microglia activation after ischemia. Ther Adv Neurol Disord. 2018 May 22;11:1756286418774254. https://doi.org/10.1177/1756286418774254
Chamorro Á, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 2016;15(8):869-881. https://doi.org/10.1016/S1474-4422(16)00114-9
Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826-837. https://doi.org/10.1038/nri2873
Frank MG, Weber MD, Watkins LR, Maier SF. Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav Immun. 2015;48:1-7. https://doi.org/10.1016/j.bbi.2015.03.010
Fettelschoss A, Kistowska M, Leibund Gut-Landmann S, Beer HD, Johansen P, Senti G, Contassot E, Bachmann MF, French LE, Oxenius A, Kundig TM. Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression. Proceedings of the National Academy of Sciences of the United States of America. 2011 Nov;108(44):18055-18060. https://doi.org/10.1073/pnas.1109176108.
Artemyeva OV, Gankovskaya LV. Inflammaging as the basis of age-associated diseases. Medical Immunology (Russia)/Meditsinskaya Immunologiya. 2020;3(22):419-432. https://doi.org/10.15789/1563-0625-IAT-1938. (In Russ.).
Lima Giacobbo B, Doorduin J, Klein HC, Dierckx RAJO, Bromberg E, de Vries EFJ. Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation. Mol Neurobiol. 2019 May;56(5):3295-3312. https://doi.org/10.1007/s12035-018-1283-6.
Chernykh AI, Komleva YK, Gorina YV, Lopatina OL, Paschenko SI, Salmina AB. Pro-inflammatory phenotype of perivascular astroglia and CD133+ progenitor cells of endotheliocytes in murine model of Alzheimer’s disease. Fundamental and Clinical Medicine. 2018;3(1):6-15. (In Russ.). https://doi.org/10.23946/2500-0764-2018-3-1-6-15.
Sajja VSSS, Hlavac N, VandeVord PJ. Role of glia in memory deficits following traumatic brain injury: Biomarkers of glia dysfunction. Frontiers in Integrative Neuroscience. 2016, February 29. https://doi.org/10.3389/fnint.2016.00007
Liang SY. Sepsis and Other Infectious Disease Emergencies in the Elderly. Emerg Med Clin North Am. 2016 Aug;34(3):501-522. https://doi.org/10.1016/j.emc.2016.04.005
Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, Yin Y, Li B, Liu G, Cai D. Hypothalamic programming of systemic ageing involving IKK-p, NF-xB and GnRH. Nature. 2013;497(7448):211-216. https://doi.org/10.1038/nature12143
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramírez-Vallejo E, Suárez JA, Zambrano LI, Villamil-Gómez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar-Apr;34:101623. https://doi.org/10.1016/j.tmaid.2020.101623
Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 Mar 14;34(2). https://doi.org/10.23812/CONTI-E
Borthwick LA. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin Immunopathol. 2016 Jul;38(4):517-534. https://doi.org/10.1007/s00281-016-0559-z
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020;77(8):1018-1027. https://doi.org/10.1001/jamaneurol.2020.2065
Becker RC. COVID-19 update: Covid-19-associated coagulopathy. Journal of thrombosis and thrombolysis. 2020;50(1):54-67. https://doi.org/10.1007/s11239-020-02134-3
Amgalan A, Othman M. Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered questions. J Thromb Haemost. 2020;18(6):1514-1516. https://doi.org/10.1111/jth.14832
Putilina MV. Current concepts about small vessel disease. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2019;119(11):65-73. (In Russ.). https://doi.org/10.17116/jnevro201911911165].
Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Complicaciones neurológicas por coronavirus y COVID-19. Rev Neurol. 2020;70(9):311‐322. https://doi.org/10.33588/rn.7009.2020179
Mao L, Wang M, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Hu Y, Li Y, Jin H, Hu B. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurol. 2020;77(6):683-690. https://doi.org/10.1001/jamaneurol.2020.1127
Acharya A, Kevadiya BD, Gendelman HE, Byrareddy SN. SARS-CoV-2 Infection Leads to Neurological Dysfunction. J Neuroimmune Pharmacol. 2020;15(2):167-173. https://doi.org/10.1007/s11481-020-09924-9
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28 [Epub ahead of print]. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2002032
Lusov VA, Evsikov EM, Teplova NV. Main causes and risk factors of development and progression of severe and malignant arterial hypertension. Russian Journal of Cardiology. 2009;4(14):6-16. (In Russ.). https://doi.org/10.15829/1560-4071-2009-4-6-16
Martin-Jimenez P, Munoz-Garcia MI, Seoane D, Roca-Rodriguez L, Garcia-Reyne A, Lalueza A, Maestro G, Folgueira D, Blanco-Palmero VA, Herrero-San Martin A, Llamas-Velasco S, Perez-Martinez DA, Gonzalez-Sanchez M, Villarejo-Galende A. Cognitive impairment is a common comorbidity in COVID-19 deceased patients. A hospital-based retrospective cohort study. medRxiv. 2020. https://doi.org/10.1101/2020.06.08.20125872
Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus. 2020 Mar;12(3):e7352. https://doi.org/10.7759/cureus.7352
Wilcox C, Zhou H. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020 Oct;129:98. https://doi.org/10.1016/j.jpsychires.2020.06.022
Hall A, Pekkala T, Polvikoski T. Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study. Alzheimers Res Ther. 2019;11(1):11. https://doi.org/10.1186/s13195-018-0450-3
Putilina MV, Natarova EB. Features of manifestations of cerebral circulation insufficiency in young patients. Russian medical news. 2002;1:41-44. (In Russ.).
Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). The provisional guidelines. Ministry of health of the Russian Federation. Ver. 7 (03.06.2020). (In Russ.).
Putilina MV, Soldatov MA. Cerebral strokes in old age. Features of the clinical picture, course, treatment. Doctor. 2006;5:29-34. (In Russ.).
Teplova NV, Evsikov EM. Angiotensin receptor Blocker Valsartan (Diovan) in clinical practice. RMZh. 2005;14:94-97. (In Russ.).
Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, Oltolini C, Castiglioni B, Din CT, Boffini N, Tomelleri A, Farina N, Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M, Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;2:325-331. https://doi.org/10.1016/S2665-9913(20)30127-2
Philip BM, Wardlaw JM. Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. International Journal of Stroke. 2015;10(4):469-478. https://doi.org/10.1111/ijs.12466
Putilina MV. Combined therapy of cerebrovascular disorders with neuroprotectors. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2016;116(11):58-63. (In Russ.). https://doi.org/10.17116/jnevro201611611158-63.
Tingbo L. Handbook of COVID-19. Prevention and Treatment. 2020. https://www.zju.edu.cn/english/2020/0323/c19573a1987520/page.htm
Liu X, Li Z, Liu S, Chen Z, Zhao Z, Huang Y-Y, Zhang Q, Wang J, Shi Y, Xu Y, Sun J, Xian H, Fang R, Bai F, Ou C, Xiong B, Lew AM, Cui J, Huang H, Zhao J, Hong X, Zhang Y, Zhou F, Luo H-B. Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction. medRxiv 2020.02.27.20027557. https://doi.org/10.1101/2020.02.27.20027557
Guo L, Rondina MT. The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases. Front Immunol. 2019;10:22-34. https://doi.org/10.3389/fimmu.2019.02204
Kalayoglu Besisik S, Ozbalak M, Tor YB, Alibeyoglu A, Kose M, Şenkal N, Cagatay A, Erelel M, Gul A, Esen F, Umman S, Isoglu Alkoclar U, Tukek T. Dipyridamole Added to Anticoagulant Prophylaxis: Decline in Poor Outcome of Clinically Severe Ill COVID-2019 Patients [abstract]. Res Pract Thromb Haemost. 2020;4(Suppl 1). https://abstracts.isth.org/abstract/dipyridamole-added-to-anticoagulant-prophylaxis-decline-in-poor-outcome-of-clinically-severe-ill-covid-2019-patients/. Accessed August 17, 2020.
Kareva EN. Features of the pharmacological actions and the use of dipyridamole in the prevention and treatment of viral infections. Consilium Medicum. 2016;18(12):80-87. (In Russ.).
Balakumar P, Nyoa Y, Renushiaa R. Classical and pleiotropic actions of dipyridamole:Not enough light toilluminate the dark tunnel? Pharmacol Res. 2014;87:144-150. https://doi.org/10.1016/j.phrs.2014.05.008
Putilina MV. The Role of endothelial dysfunction in cerebrovascular diseases. Doctor. 2012;7:24-28. (In Russ.).
Tanashyan MM, Domashenko MA. Application has chimes in chronic cerebrovascular disease. Atmosphere. Nervous diseases. 2005;3:8-11. (In Russ.).
Yakovlev AA, Gulyaeva NV. Molecular partners of cortexin in the brain. Neurochemistry. 2017;33:1:91-96. (In Russ.). https://doi.org/10.1134/S1819712416040164